Gene-Based Zika Vaccine is Safe and Immunogenic in Healthy Adults

Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults.
Source: PHPartners.org - Category: International Medicine & Public Health Source Type: news